These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 27449044)

  • 1. Sperm-associated antigen 9 (SPAG9) promotes the survival and tumor growth of triple-negative breast cancer cells.
    Jagadish N; Gupta N; Agarwal S; Parashar D; Sharma A; Fatima R; Topno AP; Kumar V; Suri A
    Tumour Biol; 2016 Oct; 37(10):13101-13110. PubMed ID: 27449044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disarib, a Specific BCL2 Inhibitor, Induces Apoptosis in Triple-Negative Breast Cancer Cells and Impedes Tumour Progression in Xenografts by Altering Mitochondria-Associated Processes.
    Manjunath M; Ravindran F; Sharma S; Siddiqua H; Raghavan SC; Choudhary B
    Int J Mol Sci; 2024 Jun; 25(12):. PubMed ID: 38928195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resveratrol exhibits diverse anti-cancer activities through epigenetic regulation of E-cadherin and p21 in triple-negative breast cancer cells.
    Sakamoto T; Tanimoto K; Eguchi H; Sasaki S; Tsuboi K; Hayashi SI; Ichihara S
    Breast Cancer; 2023 Sep; 30(5):727-738. PubMed ID: 37166625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overcoming doxorubicin resistance in triple-negative breast cancer using the class I-targeting HDAC inhibitor bocodepsin/OKI-179 to promote apoptosis.
    Smoots SG; Schreiber AR; Jackson MM; Bagby SM; Dominguez ATA; Dus ED; Binns CA; MacBeth M; Whitty PA; Diamond JR; Pitts TM
    Breast Cancer Res; 2024 Mar; 26(1):35. PubMed ID: 38429789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bruceine A: Suppressing metastasis via MEK/ERK pathway and invoking mitochondrial apoptosis in triple-negative breast cancer.
    Li X; Liu C; Zhang X; Sun C; Ling J; Liu Y; Zuo Y; Cao Y; Zhang C; Jiang T; Wang M; Liu J; Lu J
    Biomed Pharmacother; 2023 Dec; 168():115784. PubMed ID: 37879215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of eEF2K synergizes with glutaminase inhibitors or 4EBP1 depletion to suppress growth of triple-negative breast cancer cells.
    Ju Y; Ben-David Y; Rotin D; Zacksenhaus E
    Sci Rep; 2021 Apr; 11(1):9181. PubMed ID: 33911160
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ginger exosome-like nanoparticles (GELNs) induced apoptosis, cell cycle arrest, and anti-metastatic effects in triple-negative breast cancer MDA-MB-231 cells.
    Anusha R; Ashin M; Priya S
    Food Chem Toxicol; 2023 Dec; 182():114102. PubMed ID: 37865333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and mechanism of action of new purine derivatives against triple negative breast cancer.
    Zhang Q; Sun G; Huang Y; Cui S; Li T; Zhao L; Lu K; Yu P; Zhang Y; Galons H; Oumata N; Teng Y
    Eur J Med Chem; 2023 Dec; 261():115797. PubMed ID: 37708799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of a potent and selective PARP1 degrader promoting cell cycle arrest via intercepting CDC25C-CDK1 axis for treating triple-negative breast cancer.
    Wu Y; Wu M; Zheng X; Yu H; Mao X; Jin Y; Wang Y; Pang A; Zhang J; Zeng S; Xu T; Chen Y; Zhang B; Lin N; Dai H; Wang Y; Yao X; Dong X; Huang W; Che J
    Bioorg Chem; 2024 Jan; 142():106952. PubMed ID: 37952486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple suppressing small interfering RNA for cancer treatment-Application to triple-negative breast cancer.
    Lee J; Bang JH; Ryu YC; Hwang BH
    Biotechnol J; 2023 Nov; 18(11):e2300060. PubMed ID: 37478121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiapoptotic and Prometastatic Roles of Cytokine FAM3B in Triple-Negative Breast Cancer.
    Caldeira IDS; Giovanini G; Adorno LF; Fernandes D; Ramos CR; Cruz-Visalaya SR; Pacheco-Otalora LF; Siqueira FR; Nunes VA; Belizário JE; Garay-Malpartida HM
    Clin Breast Cancer; 2024 Oct; 24(7):e633-e644.e2. PubMed ID: 38997857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 2'-Hydroxyflavanone: A novel strategy for targeting breast cancer.
    Singhal J; Nagaprashantha L; Chikara S; Awasthi S; Horne D; Singhal SS
    Oncotarget; 2017 Sep; 8(43):75025-75037. PubMed ID: 29088842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycogen synthase 1 targeting reveals a metabolic vulnerability in triple-negative breast cancer.
    de Heer EC; Zois CE; Bridges E; van der Vegt B; Sheldon H; Veldman WA; Zwager MC; van der Sluis T; Haider S; Morita T; Baba O; Schröder CP; de Jong S; Harris AL; Jalving M
    J Exp Clin Cancer Res; 2023 Jun; 42(1):143. PubMed ID: 37280675
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Venkataswamy M; Karunakaran RS; Islam MS; Meriga B
    3 Biotech; 2023 Feb; 13(2):41. PubMed ID: 36643403
    [No Abstract]   [Full Text] [Related]  

  • 15. Fighting secondary triple-negative breast cancer in cerebellum: A powerful aid from a medicinal mushrooms blend.
    De Luca F; Roda E; Ratto D; Desiderio A; Venuti MT; Ramieri M; Bottone MG; Savino E; Rossi P
    Biomed Pharmacother; 2023 Mar; 159():114262. PubMed ID: 36657301
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heat shock protein 70-2 (HSP70-2) is a novel therapeutic target for colorectal cancer and is associated with tumor growth.
    Jagadish N; Parashar D; Gupta N; Agarwal S; Suri V; Kumar R; Suri V; Sadasukhi TC; Gupta A; Ansari AS; Lohiya NK; Suri A
    BMC Cancer; 2016 Jul; 16():561. PubMed ID: 27473057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heat shock protein 70-2 (HSP70-2) overexpression in breast cancer.
    Jagadish N; Agarwal S; Gupta N; Fatima R; Devi S; Kumar V; Suri V; Kumar R; Suri V; Sadasukhi TC; Gupta A; Ansari AS; Lohiya NK; Suri A
    J Exp Clin Cancer Res; 2016 Sep; 35(1):150. PubMed ID: 27658496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sperm associated antigen 9 (SPAG9) a promising therapeutic target of ovarian carcinoma.
    Jagadish N; Fatima R; Sharma A; Devi S; Suri V; Kumar V; Suri A
    Tumour Biol; 2018 May; 40(5):1010428318773652. PubMed ID: 29745297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Knockdown of A-kinase anchor protein 4 inhibits proliferation of triple-negative breast cancer cells
    Jagadish N; Devi S; Gupta N; Suri V; Suri A
    Tumour Biol; 2020 Apr; 42(4):1010428320914477. PubMed ID: 32342732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extracellular Vesicles in Triple-Negative Breast Cancer: Immune Regulation, Biomarkers, and Immunotherapeutic Potential.
    Das K; Paul S; Ghosh A; Gupta S; Mukherjee T; Shankar P; Sharma A; Keshava S; Chauhan SC; Kashyap VK; Parashar D
    Cancers (Basel); 2023 Oct; 15(19):. PubMed ID: 37835573
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.